Transcutaneous Auricular vagus nerve stimulation Effective in Treating Functional Dyspepsia

Written By :  Jacinthlyn Sylvia
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-12-27 01:30 GMT   |   Update On 2023-12-27 06:11 GMT

A recent study published in the The American Journal of Gastroenterology found that transcutaneous auricular vagal nerve stimulation (taVNS) is an effective therapeutic avenue for adults who suffer from functional dyspepsia (FD). FD is a condition marked by persistent upper abdominal discomfort that affects millions globally. This approach pf targeting the vagal nerve has remarkable...

Login or Register to read the full article

A recent study published in the The American Journal of Gastroenterology found that transcutaneous auricular vagal nerve stimulation (taVNS) is an effective therapeutic avenue for adults who suffer from functional dyspepsia (FD). FD is a condition marked by persistent upper abdominal discomfort that affects millions globally. This approach pf targeting the vagal nerve has remarkable effectiveness in modulating gastrointestinal motility, inflammation, and nociception.

The study randomly enrolled consecutive FD patients meeting Rome IV criteria. The patients were allocated to receive either 10-Hz taVNS, 25-Hz taVNS, or a sham treatment. Over a period of 4 weeks, participants underwent 30-minute sessions twice a day. The primary outcome measured was the response rate at week 4 that indicated a reduction of ≥5 points in the modified FD Symptom Diary score compared to baseline. Secondary outcomes included the rate of adequate relief and monitoring adverse events.

Among the total 300 patients enrolled, the participants in the V10 and V25 groups demonstrated significantly higher response rates (81.2% and 75.9%, respectively) compared to the sham group (47%). Both V10 and V25 groups also exhibited higher rates of adequate relief (85.1% and 80.8%, respectively) in contrast to the sham group (67%). Also, there was no statistically significant difference between the V10 and V25 groups in terms of response rates and adequate relief. The therapeutic effects of taVNS endured through weeks 8 and 12 of the follow-up period showed its lasting impact, while the adverse events were minimal and comparable across all groups (1%-3%).

This study is the first to demonstrate that a 4-week regimen of taVNS at 10 Hz or 25 Hz  which is both effective and safe for treating adult FD. The findings open new doors for non-invasive neuromodulation techniques in the context of gastrointestinal disorders that provides hope for those seeking relief from the burdens of functional dyspepsia.

Reference:

Shi, X., Zhao, L., Luo, H., Deng, H., Wang, X., Ren, G., Zhang, L., Tao, Q., Liang, S., Liu, N., Huang, X., Zhang, X., Yang, X., Sun, J., Qin, W., Kang, X., Han, Y., Pan, Y., & Fan, D. (2023). Transcutaneous auricular vagal nerve stimulation is effective for the treatment of functional dyspepsia: A multicenter, randomized controlled study. The American Journal of Gastroenterology. https://doi.org/10.14309/ajg.0000000000002548

Tags:    
Article Source : The American Journal of Gastroenterology

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News